Dolutegravir superior to standard of care in children and adolescents: results from the ODYSSEY trial
1 June 2021. Related: Conference reports, Paediatric care.
2021
High efficacy of HPV vaccine in HIV positive gay men
1 June 2021. Related: Coinfections and complications, Cancer and HIV.
HPV vaccine does not prevent short-term recurrence of high grade lesions in HIV positive gay men
1 June 2021. Related: Coinfections and complications, Cancer and HIV.
HIV bNAbs prevent intravenous exposure to SHIV in macaques as PrEP
1 June 2021. Related: HIV prevention and transmission.
HIV associated with higher risk of severe COVID-19 in US cohort
1 June 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
MHRA authorises Janssen/J&J COVID-19 vaccination in the UK
1 June 2021. Related: COVID-19: vaccine research, COVID-19.
Reduced antibody responses to first dose of mRNA COVID-19 vaccines in HIV positive people with a lower CD4 count
1 June 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19.
France routinely recommends third dose of COVID-19 vaccine for some people with reduced immune function
1 June 2021. Related: COVID-19: vaccine research, COVID-19: guidelines, COVID-19.
US CDC reports 10,000 breakthrough infections after full vaccination: showing success of vaccine programme
1 June 2021. Related: COVID-19: vaccine research, COVID-19.
Cases of COVID-19 reported including deaths in care home residents after full-course vaccination
1 June 2021. Related: COVID-19: vaccine research, COVID-19.
Israeli study reports reduced vaccine efficacy in people with immune suppression until 14 days after the second dose
1 June 2021. Related: COVID-19: vaccine research, COVID-19.
Novavax reports 43% efficacy against B.1.351 South African variant but negative impact in HIV positive participants
1 June 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19.
Oxford/AZ vaccine linked to 242 rare bloods clots in the UK: alternative recommended for people younger than 40
1 June 2021. Related: COVID-19: vaccine research, COVID-19.
COVID-19 vaccine candidate from GSK and Sanofi to move to phase 3 placebo controlled study
1 June 2021. Related: COVID-19: vaccine research, COVID-19.
Meta-analysis of 18 ivermectin studies
1 June 2021. Related: COVID-19: treatment access, COVID-19.
Asymptomatic infection has similar SARS-CoV-2 viral load to mild COVID-19
1 June 2021. Related: COVID-19: transmission & prevention, COVID-19.
Missed TB diagnoses during COVID-19 outbreaks despite prolonged respiratory symptoms
1 June 2021. Related: COVID-19: complications, COVID-19.
Correlation between COVID-19 severity and immune responses after six months
1 June 2021. Related: COVID-19: pathogenesis, COVID-19: transmission & prevention, COVID-19.
Durable antibody responses 9 months after exposure irrespective of symptoms: broader vaccine coverage still needed to reach herd immunity
1 June 2021. Related: COVID-19: pathogenesis, COVID-19: transmission & prevention, COVID-19.
HTB: no. 6 – plus HIV and COVID-19 (1 June 2021)
1 June 2021. Related: PDFs.
HTB: no. 5 – plus HIV and COVID-19 (3 May 2021)
3 May 2021. Related: Editorial, Special reports.
In memory: Paul Decle – community activist, gardener and friend
3 May 2021. Related: In memory.
Joint BHIVA/BASHH Spring Conference 2021
3 May 2021. Related: Conference reports.
BHIVA registry reports HIV is independently linked to worse presentation and outcomes from COVID-19
3 May 2021. Related: Conference reports, COVID-19: HIV and COVID-19 coinfection, COVID-19.
HIV is linked to higher mortality from COVID-19 compared to HIV negative: 60% of deaths were black ethnicity
3 May 2021. Related: Conference reports, COVID-19: HIV and COVID-19 coinfection, COVID-19.
Case-control study of HIV positive people hospitalised with COVID-19
3 May 2021. Related: Conference reports, COVID-19: HIV and COVID-19 coinfection, COVID-19.
UK government to cut international HIV support to UNAIDS by 80%
3 May 2021. Related: Treatment access.
NICE guidelines on management of chronic pain: exercise but not opiods
3 May 2021. Related: Guidelines, Side effects, Coinfections and complications.
US CDC includes HIV as medical criteria for priority to COVID-19 vaccines
3 May 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: guidelines, COVID-19.
Review of research into SARS-CoV-2 and HIV coinfection
3 May 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Similar immune responses to the Oxford/AZ COVID vaccine reported In HIV positive people with high CD4 counts
3 May 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19.
Low responses to mRNA COVID-19 vaccines in those older than 80 vs <60 years and in recipients of solid organ transplants
3 May 2021. Related: COVID-19: vaccine research, COVID-19.
Two cases of viral breakthrough infections despite full protection from Pfizer mRNA vaccination
3 May 2021. Related: COVID-19: vaccine research, COVID-19.
US post-authorisation safety data on Pfizer and Moderna vaccines
3 May 2021. Related: COVID-19: vaccine research, COVID-19.
EMA review of Oxford/AZ vaccine and rare blood clots reported in the EU
3 May 2021. Related: COVID-19: vaccine research, COVID-19.
Interim results report 80% efficacy for India’s COVAXIN vaccine
3 May 2021. Related: COVID-19: vaccine research, COVID-19.
Three new COVID-19 vaccine studies enrolling in the UK
3 May 2021. Related: COVID-19: vaccine research, COVID-19: research studies, COVID-19.
Dexamethasone: final results from RECOVERY study
3 May 2021. Related: COVID-19: investigational drugs, COVID-19.
No impact from anakinra in mild/moderate COVID-19 pneumonia
3 May 2021. Related: COVID-19: investigational drugs, COVID-19.
Bar opening in the US: 100 guests linked to at least 46 cases of COVID-19
3 May 2021. Related: COVID-19: transmission & prevention, COVID-19.
Long COVID: studies reporting on long-term follow up on COVID-19
3 May 2021. Related: COVID-19: long COVID, COVID-19: pathogenesis, COVID-19.
Large sporting event in US linked to 649 cases of COVID-19
3 May 2021. Related: COVID-19: transmission & prevention, COVID-19.
Three carefully documented cases of SARS-CoV-2 transmission in a hospital setting despite masks
3 May 2021. Related: COVID-19: transmission & prevention, COVID-19.
HTB: no.5 – plus HIV and COVID-19 (3 May 2021)
3 May 2021. Related: PDFs.
HTB: no. 4 – plus HIV and COVID-19 (1 April 2021)
1 April 2021. Related: Editorial.
28th Conference on Retroviruses on Opportunistic Infections (CROI 2021)
1 April 2021. Related: Conference reports.
CROI 2021: First results using capsid inhibitor lenacapavir against MDR HIV: potential for six-monthly ART and PrEP
1 April 2021. Related: Conference reports, Antiretrovirals.
CROI 2021: Pregnancy outcomes and weight gain with dolutegravir and TAF
1 April 2021. Related: Conference reports, Pregnancy.
CROI 2021: New compounds for prevention and treatment of COVID-19
1 April 2021. Related: Conference reports, COVID-19: investigational drugs, COVID-19.
Oral molnupiravir at higher dose reduces SARS-CoV-2 viral load at day five in small phase 2 study
1 April 2021. Related: Conference reports, COVID-19: investigational drugs, COVID-19.
Bamlanivimab prophylaxis reduces hospitalisation and mortality: results from phase 3 BLAZE-2 study
1 April 2021. Related: Conference reports, COVID-19: investigational drugs, COVID-19.
Dual Eli-Lilly mAb bamlanivimab and etesevimab reduces hospitalisation after single infusion: results from BLAZE-1 study
1 April 2021. Related: Conference reports, COVID-19: investigational drugs, COVID-19.
Dual Regeneron mAbs casirivimab with imdevimab reduce transmission: interim results from phase 3 study
1 April 2021. Related: Conference reports, COVID-19: investigational drugs, COVID-19.
CROI 2021: Presentations from the LEAP workshop 2021
1 April 2021. Related: Conference reports, Other news.
CROI 2021: Presentations on NATAP.org
1 April 2021. Related: Conference reports, Other news.
Gilead and Merck/MSD to collaborate on long-acting HIV combination of lenacapavir and islatravir
1 April 2021. Related: Antiretrovirals.
Calls to reverse proposed UK cuts to global health research
1 April 2021. Related: Other news.
BHIVA guidelines on COVID-19 vaccines and people living with HIV: DRAFT online for comment
1 April 2021. Related: Guidelines, COVID-19: guidelines, COVID-19.
BHIVA advice on access to COVID-19 vaccines and shielding in the UK
1 April 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
US phase 3 results enable FDA review of the Oxford/AstraZeneca vaccine
1 April 2021. Related: COVID-19: vaccine research, COVID-19.
HTB: no.4 – plus HIV and COVID-19 (1 April 2021)
1 April 2021. Related: PDFs.
Switch study for people with insomnia using dolutegravir
22 March 2021. Related: Research studies.
HTB: no. 3 – plus HIV and COVID-19 (12 March 2021)
12 March 2021. Related: Editorial, Special reports.
In memory: Dr Charles Boucher – leading HIV doctor, researcher and educator
12 March 2021. Related: In memory.
28th Conference on Retroviruses and Opportunistic Infections (CROI 2021)
12 March 2021. Related: Conference reports.